Abstract
Resistance to clarithromycin in H. pylori has emerged in a number of countries. We present the first documented case of H. pylori resistance to clarithromycin in Denmark. This follows an increase in the use of clarithromycin as part of the treatment of H. pylori in the most recent years in Denmark. The need for culturing and susceptibility testing in H. pylori is emphasized.
MeSH terms
-
Anti-Bacterial Agents / adverse effects
-
Anti-Bacterial Agents / therapeutic use*
-
Clarithromycin / adverse effects
-
Clarithromycin / therapeutic use*
-
Drug Resistance, Microbial*
-
Dyspepsia / drug therapy*
-
Dyspepsia / microbiology
-
Female
-
Helicobacter Infections / drug therapy*
-
Helicobacter pylori / drug effects*
-
Helicobacter pylori / immunology
-
Humans
-
Middle Aged
Substances
-
Anti-Bacterial Agents
-
Clarithromycin